Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. digipharm

DigiPharm SIGNED

Value-based Healthcare Platform Secured with Blockchain Technology

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DigiPharm project word cloud

Explore the words cloud of the DigiPharm project. It provides you a very rough idea of what is the project "DigiPharm" about.

oman    hindered    revenue    negotiation    determined    spend    price    pressure    mitigate    commercialization    frauds    people    update    dph    payments    software    pakistani    burden    initial    accelerate    incentive    abdulla    2019    contract    inadequate    technologies    cryptocurrency    ahmed    blockchain    patient    administrative    validate    cagr    plan    company    performance    switch    model    contracting    stakeholders    grant    dubai    team    uk    eases    introduction    asses    outcomes    transition    applies    2022    pricing    service    area    national    competes    expert    sme    headed    professionals    smart    platform    whom    ceo    business    entry    admin    11m    total    shift    tool    eliminates    risk    treatment    corporation    award    755m    launch    digipharm    government    operation    confidentiality    ten    2026    full    health    substantial    reluctance    economist    healthcare    continued    drastically    solution    cefact    winning    18    errors    infrastructure    viability    disruptive    roche    conventional    un    barriers    raised    resistance    market   

Project "DigiPharm" data sheet

The following table provides information about the project.

Coordinator		 DIGIPHARM SWITZERLAND GMBH 

Organization address
address: HELVETIERSTRASSE 5
city: THERWIL
postcode: 4106
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Switzerland [CH]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DIGIPHARM SWITZERLAND GMBH CH (THERWIL) coordinator 50˙000.00

Map

 Project objective

The healthcare is under pressure to spend the resources efficiently and to shift to payments by using a 'value-based' approach, where the price is determined by treatment performance and patient outcomes. However, the transition is hindered by the inadequate infrastructure, the pricing confidentiality issues, and the resistance of some stakeholders against the change. DigiPharm aims to accelerate the value-based healthcare transition with a blockchain-based smart-contracting solution and a highly disruptive business model. The solution, the award-winning DigiPharm platform drastically eases the administrative burden, eliminates errors, and potential frauds in admin operation. As a new element in healthcare, DigiPharm has introduced a cryptocurrency (DPH), as a part of an incentive system. Within the total healthcare market, DigiPharm competes in the healthcare contract management software market that will reach $755M in 2019 with CAGR of 18% in the next years. The solution has raised interest from the UK National Health Service, Roche corporation, the Oman and Dubai Health Authorities, and the Pakistani Government, with whom the company is in negotiation to test the platform. The company would like to launch the full solution in 2022 with a revenue target of €11M by 2026, although they face substantial entry barriers, such as the reluctance to switch from conventional methods and the continued funding need. In order to mitigate the risk of market introduction, Digipharm applies for the SME Tool phase 1 grant to validate DigiPharm’s business viability, asses the further technical development needs, and the update our initial commercialization plan. Currently, ten people are involved in the project development, headed by Ahmed Abdulla, CEO, health economist, an expert at UN/CEFACT, supported by a team of professionals both from the business development area and the value-based healthcare technologies.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DIGIPHARM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DIGIPHARM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

VINOQUANT11SUPERPLUS (2019)

A digital based system for measuring, showing and regulation of the complexe system of wine feremtation with high precision via a Bluetooth -Refractometer, a Software and a Bluetooth Thermostat

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More